These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32354090)

  • 1. Dry Eye Disease and Tear Cytokine Levels-A Meta-Analysis.
    Roda M; Corazza I; Bacchi Reggiani ML; Pellegrini M; Taroni L; Giannaccare G; Versura P
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
    Na KS; Mok JW; Kim JY; Rho CR; Joo CK
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study.
    Zhao CS; Chen Y; Ying GS; Asbell PA;
    Curr Eye Res; 2024 Jan; 49(1):16-24. PubMed ID: 37781912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.
    Enríquez-de-Salamanca A; Castellanos E; Stern ME; Fernández I; Carreño E; García-Vázquez C; Herreras JM; Calonge M
    Mol Vis; 2010 May; 16():862-73. PubMed ID: 20508732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tear biomarkers in dry eye disease: Progress in the last decade.
    Kumar NR; Praveen M; Narasimhan R; Khamar P; D'Souza S; Sinha-Roy A; Sethu S; Shetty R; Ghosh A
    Indian J Ophthalmol; 2023 Apr; 71(4):1190-1202. PubMed ID: 37026250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Tear Cytokine Concentrations with Symptoms and Signs of Dry Eye Disease: Baseline Data from the Dry Eye Assessment and Management (DREAM) Study.
    Roy NS; Wei Y; Ying GS; Maguire MG; Asbell PA;
    Curr Eye Res; 2023 Apr; 48(4):339-347. PubMed ID: 36632643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tear Luminex Analysis in Dry Eye Patients.
    Zhao H; Li Q; Ye M; Yu J
    Med Sci Monit; 2018 Oct; 24():7595-7602. PubMed ID: 30356032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tear Interferon-Gamma as a Biomarker for Evaporative Dry Eye Disease.
    Jackson DC; Zeng W; Wong CY; Mifsud EJ; Williamson NA; Ang CS; Vingrys AJ; Downie LE
    Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4824-4830. PubMed ID: 27654409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A latent profile analysis of tear cytokines and their association with severity of dry eye disease in the Dry Eye Assessment and Management (DREAM) study.
    Chen Y; Mallem K; Asbell PA; Ying GS
    Sci Rep; 2024 Jan; 14(1):526. PubMed ID: 38177232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. sPLA
    Wei Y; Asbell PA
    Exp Eye Res; 2020 Dec; 201():108209. PubMed ID: 33011237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection.
    Agrawal R; Balne PK; Veerappan A; Au VB; Lee B; Loo E; Ghosh A; Tong L; Teoh SC; Connolly J; Tan P
    Cytokine; 2016 Dec; 88():77-84. PubMed ID: 27585367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial.
    Pinto-Fraga J; Enríquez-de-Salamanca A; Calonge M; González-García MJ; López-Miguel A; López-de la Rosa A; García-Vázquez C; Calder V; Stern ME; Fernández I
    Ocul Surf; 2018 Jul; 16(3):368-376. PubMed ID: 29772277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Conjunctival Staining to Measure Ocular Surface Inflammation in Patients With Dry Eye.
    Yang S; Lee HJ; Kim DY; Shin S; Barabino S; Chung SH
    Cornea; 2019 Jun; 38(6):698-705. PubMed ID: 30844839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures.
    Wei Y; Gadaria-Rathod N; Epstein S; Asbell P
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8327-36. PubMed ID: 24204044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R; Huang R; Li K; Zhang X; Yang H; Quan Y; Li Q
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model.
    Cocho L; Fernández I; Calonge M; Martínez V; González-García MJ; Caballero D; López-Corral L; García-Vázquez C; Vázquez L; Stern ME; Enríquez-de-Salamanca A
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):746-58. PubMed ID: 26927568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear Proteomics Study of Dry Eye Disease: Which Eye Do You Adopt as the Representative Eye for the Study?
    Kuo MT; Fang PC; Kuo SF; Chen A; Huang YT
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival cytokine expression in symptomatic moderate dry eye subjects.
    Narayanan S; Miller WL; McDermott AM
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2445-50. PubMed ID: 16723455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
    Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.